Closing Bell Recap: Esperion Therapeutics Inc (ESPR) Ends at 1.06, Reflecting a -11.67 Downturn

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $1.06 down -11.67% from the previous closing price of $1.20. In other words, the price has decreased by -$11.67 from its previous closing price. On the day, 6.15 million shares were traded.

Ratios:

For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.

On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.

BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’25 when Halladay Benjamin sold 3,535 shares for $1.48 per share. The transaction valued at 5,242 led to the insider holds 481,710 shares of the business.

Warren Eric sold 2,433 shares of ESPR for $3,618 on Mar 18 ’25. The Chief Commercial Officer now owns 370,326 shares after completing the transaction at $1.49 per share. On Mar 18 ’25, another insider, Koenig Sheldon L., who serves as the President and CEO of the company, sold 13,047 shares for $1.50 each. As a result, the insider received 19,623 and left with 1,571,962 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63.

Stock Price History:

Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -36.30%, while the 200-Day Moving Average is calculated to be -48.28%.

Shares Statistics:

A total of 195.85M shares are outstanding, with a floating share count of 194.37M. Insiders hold about 1.76% of the company’s shares, while institutions hold 65.68% stake in the company.

Most Popular